Epodyl treatment of bladder tumours.
Multiple, non-invasive bladder papillomas were treated with intravesical instillation of Epodyl in 44 patients. Irritative cystitis occurred in 16 per cent of the series, and in these cases Epodyl treatment had to be stopped. Total or partial disappearance of the papillomas was seen after 16 months of treatment in 43% of the total series. This was the minimum success rate, since all the patients who left the study were counted as failures. When the treatment could be carried through, total or partial disappearance of papillomas occurred in 19 of 29 patients (66%). Epodyl has a place in the treatment of vesical papillomas when other methods have failed.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D003556:Cystitis / Q000139:chemically induced; D004341:Drug Evaluation; D004987:Ethers / Q000627:therapeutic use*; D005009:Ethoglucid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy; D010212:Papilloma / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014546:Urinary Catheterization
D004987:Ethers; D005009:Ethoglucid